October 2017, Vol 7, No 10

By now all oncologists know that the implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is shifting physician reimbursement from a volume- to a value-based model. To succeed with MACRA, practices must become familiar with how this will affect them and get ready to incorporate the new measures to ensure they get the best level of reimbursement under this program. Read More ›

Read More ›

Read More ›

Integrating research findings and clinical trial evidence into healthcare policy and clinical practice is not always simple, according to David Chambers, DPhil, MSc, Deputy Director for Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute, at the 2017 Quality Care Symposium. Read More ›

Read More ›

Read More ›

Read More ›